Ankie M. Harmsze

Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation

Nicoline J. Breet, Jochem W. van Werkum, Heleen Bouman et al. · JAMA · 2010 · 840 citations

Platelet Function, Platelet Works, Coronary Artery Disease +16

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study

Ankie M. Harmsze, Jochem W. van Werkum, Jurriën M. ten Berg et al. · European Heart Journal · 2010 · 161 citations · Full text

Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting

Heleen Bouman, Ankie M. Harmsze, Jochem W. van Werkum et al. · Heart · 2011 · 94 citations

Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation

Ankie M. Harmsze, Jochem W. van Werkum, Heleen Bouman et al. · Pharmacogenetics and Genomics · 2009 · 93 citations

High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention

Nicoline J. Breet, Jochem W. van Werkum, Heleen Bouman et al. · Heart · 2011 · 85 citations